Blair William & Co. IL Trims Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Blair William & Co. IL lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 15.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 172,705 shares of the pharmacy operator’s stock after selling 30,798 shares during the period. Blair William & Co. IL’s holdings in Walgreens Boots Alliance were worth $1,611,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Swedbank AB lifted its stake in shares of Walgreens Boots Alliance by 45.3% in the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after acquiring an additional 185,762 shares during the period. Sunbelt Securities Inc. lifted its position in Walgreens Boots Alliance by 82.8% in the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator’s stock valued at $1,249,000 after purchasing an additional 63,149 shares during the period. Merit Financial Group LLC purchased a new stake in Walgreens Boots Alliance in the 4th quarter valued at approximately $326,000. FMR LLC increased its position in Walgreens Boots Alliance by 2.5% during the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after purchasing an additional 80,525 shares during the period. Finally, Redwood Investment Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 67.0% in the 3rd quarter. Redwood Investment Management LLC now owns 210,179 shares of the pharmacy operator’s stock valued at $1,903,000 after buying an additional 84,303 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on WBA shares. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, March 26th. They issued a “hold” rating for the company. Bank of America upped their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Trading Down 0.1 %

Walgreens Boots Alliance stock opened at $11.16 on Wednesday. The stock has a market cap of $9.64 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average price of $10.80 and a 200 day moving average price of $9.95. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $19.62.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 earnings per share. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.